Lyell Immunopharma, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Lyell Immunopharma, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

H.C. Wainwright 27th Annual Global Investment Conference

Sep 10, 2025

Transcript

Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025

Transcript

Q2 2025

Aug 12, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 13, 2025

Earnings release8-K

Quarterly report10-Q

43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025

Slides

2024

Q4 2024

Mar 11, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 7, 2024

Earnings release8-K

Quarterly report10-Q

M&A Announcement

Oct 24, 2024

Press release

Slides

Q2 2024

Aug 7, 2024

Earnings release8-K

Quarterly report10-Q

Study Update

Jun 26, 2024

Press release

Slides

Q1 2024

May 6, 2024

Earnings release8-K

Quarterly report10-Q

Slides

J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 10, 2024

Slides

2023

Q4 2023

Feb 28, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 7, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 8, 2023

Earnings release8-K

Quarterly report10-Q

Q1 2023

May 4, 2023

Earnings release8-K

Quarterly report10-Q

2022

Q4 2022

Feb 28, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 8, 2022

Earnings release8-K

Quarterly report10-Q

Q2 2022

Aug 4, 2022

Quarterly report10-Q

Q1 2022

May 9, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 29, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 12, 2021

Earnings release8-K

Quarterly report10-Q

Q2 2021

Aug 12, 2021

Earnings release8-K

Quarterly report10-Q